Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
SWOG Cancer Research Network
City of Hope Medical Center
Novartis
City of Hope Medical Center
City of Hope Medical Center
Fundacion CRIS de Investigación para Vencer el Cáncer
Masaryk University